Data and Intellectual Property. Technology and Patent Rights owned by either Party at the Effective Date pertaining to Products and/or Technology, and Technology and Patent Rights that are developed and owned by a Party during the term of this Agreement (including, without limitation, ownership as set forth in this Agreement) will remain the sole property of the owning Party, which that Party may exploit in any manner it chooses at its sole discretion, except to the extent otherwise provided in this Agreement. New Invention(s) made by Ambrx and/or Elanco in connection with Products and/or Technology during the term of this Agreement, and any patents, copyrights or other intellectual property based on such Invention(s), will be owned by the Party(ies) of which the inventor(s) is an employee or agent, except as expressly set forth in this Agreement.
Data and Intellectual Property. Data, Patent Rights and Know-How Controlled by either Party as of the Effective Date or during the Term (including ownership as set forth in this Agreement) will remain, as between the Parties, the sole property of the Controlling Party, which that Party may exploit in any manner it chooses at its sole discretion, except to the extent otherwise provided in this Agreement. Any invention(s) made by NextCure and/or Lilly in connection with Collaboration Targets and/or Products during the Term outside the Party’s performance of its responsibilities under this Agreement, and any Patent Rights, Know-How, copyrights or other intellectual property based on such invention(s), will be owned by the Party(ies) of which the inventor(s) is an employee, contractor or agent, but shall be subject to the provisions of Article 7.
Data and Intellectual Property. (a) All Data shall be and remain the property of the party contributing same. Intellectual property rights, including patent rights, for any Intellectual Property developed with respect to the Demonstration Project or otherwise in connection with this agreement or the EPI Technology shall vest fully and unconditionally in EPI, and EPI shall have the sole and exclusive right to pursue patent protection for such Intellectual Property. MegaWest agrees to and hereby assigns all of MegaWest’s right, title, and interest in and to all intellectual property rights, including patent rights, for any Intellectual Property developed with respect to the Demonstration Project or otherwise in connection with this agreement or the EPI Technology. MegaWest agrees to execute, whenever requested by EPI, all patent applications, assignments, lawful oaths and any other papers which EPI may deem necessary or desirable for securing to EPI or for maintaining for EPI all the intellectual property, patent(s), patent application(s) and equivalent rights hereby assigned and agreed to be assigned; all without further compensation to MegaWest.
(b) The Parties recognize that EPI is not required or obligated to disclose EPI Technology under the terms of this Agreement. This Agreement shall not be construed as granting a license to any EPI Technology.
(c) MegaWest agrees that at all times EPI shall be free to negotiate and/or enter into business transactions with third parties with respect to the development of other projects utilizing the EPI Technology in Canada and elsewhere, without restriction or limitation.
Data and Intellectual Property. (a) Color may use the Samples and all information that is provided to Color in a TRF (“Data”) as necessary in connection with its performance of Services hereunder. Except as expressly set forth in this Agreement, neither party grants to the other by implication, estoppel or otherwise, any right, title, license or interest in any intellectual property rights. Color owns all right, title and interest (including patent rights, copyrights, trade secret rights, mask work rights, trademark rights, and all other intellectual property rights of any kind throughout the world) in and to Services, including all Tests and related documentation, Color’s web portal and software, its marketing materials and content displayed or provided as part of the Services and Tests as well as all copies and derivative works thereof (collectively, the “Color Property”).
(b) Prior to allowing an Eligible Individual to use and access Services, each Eligible Individual shall be required to provide consent to the Testing. Color shall use an Eligible Individual’s Data solely to perform the Services and as otherwise authorized by the Eligible Individual or as permitted by Applicable Law or health order, for example, use of de-identified data provided by an Eligible Individual and/or their Test results for quality assurance, lab validation, and Testing improvement purposes..
Data and Intellectual Property. (a) Except as set forth in Schedule 2.17, the Company has the unrestricted right to use and holds the copyright to all of the data which comprise all of its databases including data taken directly from any and all external sources as well as derived data.
(b) Except as set forth on Schedule 2.17, (i) the Company has not been sued or charged or been a defendant in any claim, suit, action or proceeding which involves a claim of infringement of any intellectual property rights, (ii) to the knowledge of such Seller, there are no other claims that the Company is infringing any existing patent, trademark or copyright or any basis for any such claim, without regard to whether any such patent, trademark or copyright is ultimately found to be valid, and (iii) to the knowledge of such Seller, the use of intellectual property rights in connection with the Business, as currently being conducted, does not infringe the patent, trademark, copyright or any other right of any third party.
Data and Intellectual Property. 4.1 Any and all data generated from the use of Annamycin API and Annamycin DP by a Party shall be the property of that Party, provided however, the other Party shall have the right to use such data subject to the confidentiality provisions set forth in Article 7 of this Agreement.
4.2 Any New Intellectual Property shall be the property of MBI, provided however, that Dermin shall have an option to license New Intellectual Property under the terms and conditions set forth in the Original License Agreement. Dermin shall exercise its option under this Section 4.2 by written notice to MBI.
Data and Intellectual Property. A. Data. All data and materials (including MOLECULAR CONNECTIONS manuals, indexing guidelines, and other documentation), proprietary tools supplied by MOLECULAR CONNECTIONS shall be and remain the exclusive property of MOLECULAR CONNECTIONS. Furthermore, all data processed by CONSULTANT for MOLECULAR CONNECTIONS shall be and remain the exclusive property of MOLECULAR CONNECTIONS.
B. Under no circumstances shall CONSULTANT merge or otherwise incorporate the Input Materials or the Deliverables with any other database that CONSULTANT owns, builds, or operates for itself or any third party. Violation of this clause shall be considered a substantial breach of this Agreement.
Data and Intellectual Property. Address ownership and rights to the data and intellectual property generated or used in connection with the blockchain project. - Specify any licensing or usage rights granted to the Parties.
Data and Intellectual Property. Section 11.1
Data and Intellectual Property. The present Agreement does not imply any transfer of exclusive rights in any form and in any scope from one Party to the other Party, unless it is expressly provided by the present Agreement. For the purpose of the present Agreement and exclusively for the sake of performance by Criteo of its obligations under the present Agreement the Client grants to Criteo the right to use the Client Data in the following ways: (i) to collect, use, analyse and process the Client Data, to combine the Client Data with Criteo Data and Criteo Sourced Data and to perform the Service, for the Client; (ii) to improve Criteo Technology, Criteo Service and other Criteo products, programs and/or services with aggregated Client Data; and (iii) to disclose Client Data if required by law. In case the aforementioned Client Data is an object of intellectual rights (including copyright), the Client grants to Criteo license to use such Client Data in the ways described above during the time period of this Agreement is effective worldwide. At that, the Client cannot claim any consideration for this license except for the Criteo Service itself within the limits and with 7. Данные и интеллектуальная собственность Настоящий Договор не предполагает перехода исключительных прав в какой-либо форме и в каком-либо объеме от одной Стороны к другой, за исключением случаев, прямо предусмотренных настоящим Договором. В целях исполнения настоящего Договора и исключительно для того, чтобы Criteo имело возможность исполнить свои обязательства по настоящему Договору, Клиент предоставляет Criteo право использовать Данные Клиента следующим образом: (i) собирать, использовать, анализировать и обрабатывать Данные Клиента, объединять Данные Клиента с Данными Criteo и Данными, получаемыми Criteo из других источников, и предоставлять Услугу Клиенту; (ii) совершенствовать Технологии Criteo, улучшать Услугу Criteo и другие продукты, программы и/или услуги Criteo при помощи использования Комплекса данных Клиента, а также В том случае, если вышеуказанные Данные Клиента являются объектом интеллектуальных прав (в том числе авторского права), Клиент the reservations expressly provided by the present Agreement. Furthermore, during the time period this Agreement, the Client grants to Criteo license to use trademarks and logos (copyrighted work) of the Client (the list of such trademarks and logos is provided to Criteo by the Client) by reproducing and representing them worldwide, as well as to display, reproduce and re...
